Norman E. Sharpless
Affiliations: | Genetics & Molecular Biology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Genetics, Molecular BiologyGoogle:
"Norman Sharpless"Children
Sign in to add traineeKimberly Monahan | grad student | 2009 | UNC Chapel Hill |
Soren M. Johnson | grad student | 2010 | UNC Chapel Hill |
William R. Jeck | grad student | 2013 | UNC Chapel Hill |
Jessica A. Sorrentino | grad student | 2013 | UNC Chapel Hill |
Shenghui He | post-doc | 2013-2017 | UNC Chapel Hill (Neurotree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Souroullas GP, Jeck WR, Parker JS, et al. (2024) Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nature Medicine |
Liu JY, Souroullas GP, Diekman BO, et al. (2019) Cells exhibiting strong promoter activation in vivo display features of senescence. Proceedings of the National Academy of Sciences of the United States of America |
Zhao X, Little P, Hoyle AP, et al. (2018) The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma. Frontiers in Oncology. 8: 584 |
Diekman BO, Sessions GA, Collins JA, et al. (2018) Expression of p16 is a biomarker of chondrocyte aging but does not cause osteoarthritis. Aging Cell. e12771 |
Sewastianik T, Jiang M, Sukhdeo K, et al. (2017) Constitutive Ras signaling and Ink4a/Arf inactivation cooperate during the development of B-ALL in mice. Blood Advances. 1: 2361-2374 |
Brighton HE, Angus SP, Bo T, et al. (2017) New mechanisms of resistance to MEK inhibitors in melanoma revealed by intravital imaging. Cancer Research |
Liu W, Snell JM, Jeck WR, et al. (2017) Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. Jci Insight. 2 |
Deng J, Wang ES, Jenkins RW, et al. (2017) CDK4/6 Inhibition Augments Anti-Tumor Immunity by Enhancing T Cell Activation. Cancer Discovery |
Hong A, Moriceau G, Sun L, et al. (2017) Exploiting drug addiction mechanisms to select against MAPKi-resistant melanoma. Cancer Discovery |
He S, Sharpless NE. (2017) Senescence in Health and Disease. Cell. 169: 1000-1011 |